Skip to main content

Agilent Acquires GE Healthcare's Chemiluminescence Line to Bolster Gas Chromatographs

NEW YORK (GenomeWeb News) — Agilent Technologies has purchased the chemiluminescence product line from GE Healthcare’s Analytical Instruments segment, Agilent said today.
 
The deal includes intellectual property, sales, marketing, and manufacturing assets.
 
New products Agilent acquired through the deal include sulfur and nitrogen chemiluminescence detectors that Agilent said it will incorporate into its Chemical Analysis Solutions unit.  
 
Agilent said it will offer the products as add-ons to its gas chromatographs.
 
Financial terms of the deal were not released.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.